PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 198 (xsd:integer)
nif:isString
  • Agents such as sorafenib, thalidomide, HIF2α, octreotide and immunotherapy may seem promising, but more preclinical and larger patient studies are needed to assess their efficacy and safety profile.
rdf:type